Jeff Rusinow
Chairman @ Aurora Spectral Technologies
Milwaukee, United States
Jeff Rusinow is a Series A investor at Aurora Spectral Technologies in Milwaukee focused on Health Care and Medical. Jeff Rusinow is the founder in 2000 of Milwaukee's first angel network, Silicon Pastures. He has invested in about 55 pre-revenue startups, 8 of which have had exits, two of which have been acquired by Fortune 500 companies. See jeffrusinow.com. He is Chairman and Lead Investor at MediCardia Health, Inc.Jeff is also an avid birder. Hehas identified over 821 species of birds in the ABA Area (U.S. & Canada). He is also the sole owner of ETR Group, LLC, which once owned Christmas.com.Jeff Rusinow has both a B.A. and M.A. from the
- Total investments:
- 14
- Last investment:
- Lead investor:
- 21%
Last updated:
For AI agents: llms.txt
Industries Jeff Rusinow invests in
Stages Jeff Rusinow invests in
Countries Jeff Rusinow invests in
Round sizes
Round size
- Seed
- $800k–$2M
- Series A
- $1.5M–$3M
Investment Focus
Industry
- Health Care 5 (36%)
- Medical 4 (29%)
- Software 2 (14%)
- SaaS 1 (7%)
- Beauty 1 (7%)
Stage
- Series A 4 (29%)
- Seed 3 (21%)
- Funding Round 3 (21%)
- Angel 1 (7%)
- Pre-Seed 1 (7%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
MediCardia is the first digital health platform that aggregates, organizes and operationalizes comprehensive clinical data for the clinician. MediCardia's virtual care platform serves as a unified and common interface for EHRs and remote technologies including wearables, consumer home medical devices, and implanted cardiac rhythm devices.With embedded video and smart design, our core platform includes the patent-pending HeartChart scoring algorithm, advanced natural language processing (NLP) for data discretization, automated chart preparation, and soon to be launched imaging, a search platform, second opinion, and a proprietary clinical intelligence engine. | $3M / Series A / Oct 21, 2021 | |
|
|
MediCardia is the first digital health platform that aggregates, organizes and operationalizes comprehensive clinical data for the clinician. MediCardia's virtual care platform serves as a unified and common interface for EHRs and remote technologies including wearables, consumer home medical devices, and implanted cardiac rhythm devices.With embedded video and smart design, our core platform includes the patent-pending HeartChart scoring algorithm, advanced natural language processing (NLP) for data discretization, automated chart preparation, and soon to be launched imaging, a search platform, second opinion, and a proprietary clinical intelligence engine. | $1M / Pre-Seed / Mar 01, 2020 | |
|
|
ImageMoverMD is a medical imaging software company that integrates enterprise imaging and electronic health record systems. The company's innovative solutions employ an exclusive approach to securely connect photos, video, and outside medical images with the EHR, simplifying communication, and enhancing patient care. It transforms enterpriseimaging to improve the quality and cost of care while optimizing patient and provider experience.ImagerMoverMD using web-native automation applications that integrate with both the EMR and the VNA/PACs systems, the ImageMover platform measurably improves efficiency, increases revenue capture, and drives HIPAA compliance across the entire care continuum. It also provides end-to-end imaging optimization for health systems. | $1.2M / Aug 30, 2017 | |
|
|
Launched in 2012, Wantable, Inc. is a discovery e-commerce company that sends customers hand-picked and personalized beauty, fashion accessories, or luxury intimate apparel items.Wantable sends customers on-trend boutique, speciality, and premium products that we feel she would want to discover. Top brands like Kiby's, ncLA, and VincentLongo, along with boutique brands like (PLA) Beauty, Liberty Republic, and Soxxy have partnered with Wantable. | $814K / Series C / Dec 14, 2016 | |
|
|
HealthMyne’s mission is to provide clinicians with real-time evidence-based imaging insights and solutions that significantly aid in improved decision-making for optimized patient care and reduced care delivery cost. | $6.9M / Sep 26, 2016 | |
|
|
Launched in 2012, Wantable, Inc. is a discovery e-commerce company that sends customers hand-picked and personalized beauty, fashion accessories, or luxury intimate apparel items.Wantable sends customers on-trend boutique, speciality, and premium products that we feel she would want to discover. Top brands like Kiby's, ncLA, and VincentLongo, along with boutique brands like (PLA) Beauty, Liberty Republic, and Soxxy have partnered with Wantable. | $2M / Series B / Mar 12, 2016 | |
|
|
Founded in March 2012 in partnership with the Medical College of Wisconsin, Somna Therapeutics is a medical device company focused on improving the quality of life for the millions of people suffering from laryngopharyngeal reflux (LPR) / extraesophageal acid reflux disease (EERD). The Reza Band™, UES Assist Device is designed to be anon-invasive solution. In the near-term, Somna Therapeutics is planning to optimize product design and complete clinical trials to gain FDA clearance. We anticipate upon FDA clearance and product launch, to be selling to hospitals, physician clinics, and home health care. | $700K / Angel / Oct 01, 2014 | |
|
|
Launched in 2012, Wantable, Inc. is a discovery e-commerce company that sends customers hand-picked and personalized beauty, fashion accessories, or luxury intimate apparel items.Wantable sends customers on-trend boutique, speciality, and premium products that we feel she would want to discover. Top brands like Kiby's, ncLA, and VincentLongo, along with boutique brands like (PLA) Beauty, Liberty Republic, and Soxxy have partnered with Wantable. | $1.5M / Series A / Jul 31, 2014 | |
|
|
ReviewTrackers is a customer feedback software that is used to measure and transform the customer experience. Its platform collects review data from review sites to generate new reviews that engage its customers and listen and respond to their comments to discover key business insights that enable brands to listen, comprehend and make data-drivendecisions about what their customers truly need or want.ReviewTrackers helps busy professionals save time, money and resources so they can focus on what matters most of their customers. It was founded in 2012 and is headquartered in Chicago, Illinois. | $2M / Seed / Jun 17, 2014 | |
|
|
ReviewTrackers is a customer feedback software that is used to measure and transform the customer experience. Its platform collects review data from review sites to generate new reviews that engage its customers and listen and respond to their comments to discover key business insights that enable brands to listen, comprehend and make data-drivendecisions about what their customers truly need or want.ReviewTrackers helps busy professionals save time, money and resources so they can focus on what matters most of their customers. It was founded in 2012 and is headquartered in Chicago, Illinois. | $2M / Series A / Jun 17, 2014 | |
| See all 14 investments → | |||
Co-Investors
About Aurora Spectral Technologies
Aurora Spectral Technologies LLC, a development stage company, intends to develop and commercialize tools for imaging proteins in living cells. The company was founded in 2010 and is based in Brooklyn, Wisconsin.
Aurora Spectral Technologies Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Jeff Rusinow
Chairman
|
|||
|
Valerica Raicu
Co-Founder
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Jeff Rusinow invest in?
Jeff Rusinow invests primarily in Health Care, Medical and Software startups, most often at Series A and Seed stage. Most of the 14 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Jeff Rusinow's check size?
Jeff Rusinow typically joins rounds of $800k–$2M at Seed and $1.5M–$3M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Jeff Rusinow participates in.
When did Jeff Rusinow last invest?
The most recent investment recorded for Jeff Rusinow closed in Oct 2021. Shizune tracks 14 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!